Investigating Biomarkers in Acute Respiratory Distress Syndrome
Official title: The ASSESSMENT of SERPINB3 EXPRESSION, PAR2 and SCCA-PD POLYMORPHISM in PATIENTS with ACUTE RESPIRATORY DISTRESS SYNDROME
Run by University of Padova · NCT06774534 · Data updated 2026-11-12
This study is trying to see if certain markers in the blood can help us understand how Acute Respiratory Distress Syndrome affects the lungs and how severe the condition is in patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Padova Academic / other |
| Locations | 1 site (Padova, PD) |
| Status | Recruiting |
| Started | February 28, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2030 |
| Registry record updated | March 5, 2025 |
| Trial ID | NCT06774534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults diagnosed with ARDS who require invasive mechanical ventilation.
✕Probably not a fit
Patients under 18 years, pregnant individuals, or those with chronic inflammatory skin conditions or chronic lung diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients diagnosed with Acute Respiratory Distress Syndrome (ARDS) and aims to explore the expression of SERPINB3 and the polymorphism SCCA-PD, as well as the role of protease-activated receptor 2 (PAR2) in the disease's pathophysiology. By conducting a detailed clinical and biomolecular phenotyping, the study seeks to uncover new insights into the mechanisms of lung injury associated with ARDS. The research will analyze how these biomarkers correlate with the severity of lung injury and inflammation in affected patients.
Why it matters
Potential benefit: If successful, this study could lead to personalized treatment strategies for ARDS patients based on their specific biomolecular profiles.
How similar studies have gone: While the specific approach of studying SERPINB3 and PAR2 in ARDS is novel, similar studies have shown promise in understanding biomarkers in other respiratory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ARDS DIAGNOSIS * IMV Exclusion Criteria: * Age under 18 years * Pregnancy status * Lack of consent to participate in the study * Contraindications to fiberoptic bronchoscopy and/or BAL (bronchoalveolar lavage) * Patients with chronic inflammatory skin conditions * Patients with chronic lung diseases * Patients with inflammatory respiratory diseases * Patients with neoplasms such as: squamous cell carcinoma of the cervix, squamous cell carcinoma of the esophagus, lung adenocarcinoma, breast adenocarcinoma, pancreatic adenocarcinoma, hepatocellular carcinoma * History of active or passive smoking
Where it's running
-
Azienda Ospedaliera di Padova
Padova, Pd, Italy Recruiting
Study contacts
- Study coordinator: Annalisa Boscolo, Professor
- Email: annalisa.boscolo@gmail.com
- Phone: +393498324972
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HFNC During Bronchoscopy for Respiratory Failure
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Surfactant delivery methods in preterm infants with RDS in Sweden
This study tests different ways of giving surfactant to preterm babies with respiratory distress to see which method works best when care is routine.
-
Breathing patterns in preterm infants before and after extubation.
This will try to see if measuring work of breathing with soft chest and abdominal bands can predict which intubated premature infants (≤32 weeks) will tolerate removal of their breathing tube.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.